Global Diabetes Devices Market: Scope and Methodology This report on the global diabetes devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global diabetes devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global diabetes devices market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global optometry market.
Diabetes Devices Market: Segmentation Diabetes Mellitus is a chronic condition in which our body is unable to produce or utilize insulin for converting blood glucose into energy. Globally around 415 million people are living with diabetes. Half of the world’s population suffering with diabetes still remains undiagnosed. It is studied that 90% of diabetes cases are of type 2 diabetes. The diabetes devices market has a huge scope during the forecast period. The global diabetes devices market can be segmented based on product type, distribution channel and region.
Depending on the product type the global diabetes devices market includes Glucose Monitoring Devices, Insulin Delivery Devices, Diabetes Monitoring Software and Artificial Pancreas System. The Glucose Monitoring Devices includes four main sub-segments viz. self -monitoring blood glucose meters, blood glucose testing strips, lancets and continuous glucose monitoring meters.
Insulin delivery devices segment includes insulin syringes, insulin pens and insulin pumps. The Glucose Monitoring Devices segment is projected to be a highly attractive segment of the global diabetes devices market during the forecast period. The segment is anticipated to be expand at a CAGR of 6.7% during the forecast period. Self- monitoring blood glucose meters segment contributes maximum share to the global diabetes devices market in terms of revenue.
High prevalence of diabetes due to factors such as lifestyle changes, high life expectancy and increased urbanization drives this segment of the Diabetes Devices market as people have become more careful about their health conditions and thus regularly monitor their blood glucose levels.
Based on the distribution channel, the global diabetes devices market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and diabetes clinics/centers. The hospital pharmacy segment contributes maximum share in terms of revenue in the forecast period.
Diabetes Devices Market: Geographical and Competitive Dynamics Geographically, the global diabetes devices market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.
The report also profiles major players in the diabetes devices market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Medtronic plc, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd.
Global diabetes devices market is segmented as follows: Global Diabetes Devices Market Revenue, by Product Type Glucose Monitoring Devices Self- monitoring blood glucose meters Blood glucose testing strips Lancets Continuous glucose monitoring meters Insulin Delivery Devices Insulin syringes Insulin pens Insulin pumps Diabetes Management Software Artificial Pancreas System
Global Diabetes Devices Market Revenue, by Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Diabetes Clinics/ Centres
Global Diabetes Devices Market Revenue, by Region North America US Canada Europe Germany France Italy Spain UK Rest of Europe Asia Pacific China Japan India Australia & New Zealand Rest of Asia Pacific Middle East and Africa GCC countries South Africa Rest of Middle East & Africa Latin America Brazil Mexico Rest of Latin America
Our reports have been used by over 10K customers, including:
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Diabetic Foot Ulcers Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Diabetic Foot Ulcers pipeline products. The Diabetic Foot Ulcers pipeline guide presents complete overview of drugs currently...
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Diabetic Gastroparesis Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Diabetic Gastroparesis pipeline products. The Diabetic Gastroparesis pipeline guide presents complete overview of drugs...
The insulin pumps market is estimated to account for US$ 8,264.01 Mn by the end of 2025, escalating at a CAGR of 10.5% during the forecast period from 2018 to 2025, rising from US$ 3,822.44 Mn in 2017. The increasing rise in the geriatric population is the significant factor that is expected to drive the growth of the global insulin pumps...
The hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4% during the forecast period. The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. Technological advancements in hemodynamic...
The pen needles market is estimated to account for US$ 2,280.6 Mn by the end of 2025, escalating at a CAGR of 4.6% during the forecast period from 2018 to 2025, rising from US$ 1,603.8 Mn in 2017. The rise in the number patients suffering from diabetes as well as increasing obese population that is at high risk of diabetes are expected to...
285 pages •
By Global Industry Analysts
• Aug 2018
This report analyzes the worldwide markets for Biosensors in US$ Thousand by the following Product Applications: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...